Cancer cell-derived IL-6 activates the STAT3 pathway in MDSCs, subsequently upregulating indoleamine 2,3-dioxygenase in co-cultures of human CD33(+) myeloid progenitors with MDA-MB-231 breast cancer cells [141]. Here, IL6 is linked to cancer.